Skip to content

Author

Ming-Jun Zhu

We have 3 of 33 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Therapeutic Targeting of Viral Myocarditis with Natural Products and Herbal Medicines: From Immune-Inflammatory Mechanisms to Clinical Translation

Overall, natural products and herbal medicines should currently be regarded as promising adjunctive candidates whose clinical value depends on stronger, stage-specific, and methodologically robust evidence.

Wen-Jun Wu, Xue Li, Rui Yu et al. · 0 citations
Sep 2026

Sodium tanshinone IIA sulfonate attenuates pulmonary vascular remodeling by targeting DYRK1A in pulmonary hypertension.

BACKGROUND Pulmonary hypertension (PH) is a progressive disorder marked by elevated pulmonary artery (PA) pressure and vascular remodeling, often leading to right heart failure. A key feature is pulmonary artery smooth muscle cells (PASMC) phenotypic switching from a contractile to a synthetic state, which drives media...

Zheng-Wei Dong, Qian-Qian Lu, Zhi-Feng Xue et al. · 0 citations
Review Open access Jul 2026

Inflammatory responses driven by neutrophil extracellular traps in cardiovascular diseases: molecular mechanisms, emerging biomarkers, and therapeutic targets

The mechanisms by which NETs mediate inflammatory responses in CVD are summarized and the potential of NETs as inflammation-related biomarkers and therapeutic targets are explored, with the aim of providing new insights into inflammation-based strategies for the prevention and treatment of CVD.

Aolong Wang, Jing-Jing Wei, Rui Yu et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.